OMEGA PROTEIN CORP
Consumer Staples · Fats & Oils · NV · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | |
|---|---|---|---|---|---|---|
| Revenue | $84.8M | $71.6M | $308.6M | $244.3M | $235.6M | $251.7M |
| Operating income | $14.6M | $3.7M | $31.6M | $48.0M | $12.6M | $54.4M |
| Net income | $8.4M | $1.7M | $18.5M | $30.5M | $4.1M | $34.2M |
| Total assets | $431.3M | $407.2M | $380.1M | $331.4M | $295.3M | $277.8M |
| Total liabilities | $94.6M | $112.0M | $114.2M | $84.2M | $89.7M | $81.3M |
| Equity | $336.7M | $295.2M | $265.9M | $247.2M | $205.6M | $196.6M |
| EPS (diluted) | $0.37 | $0.08 | $0.85 | $1.45 | $0.20 | $1.71 |
| Shares out. | 22.2M | 21.6M | 20.9M | 19.9M | 19.6M | 19.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2016- Operating margin
- 17.3%
- Net margin
- 9.9%
- Return on equity
- 2.5%
- Return on assets
- 1.9%
- Return on capital (ROCE)
- 3.9%
- Liabilities / assets
- 21.9%
- Debt / equity
- 0.28×
- Book value / share
- $15.16
- Revenue growth (YoY)
- 18.5%
- Net income growth (YoY)
- 402.1%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2016- Altman Z″ (distress)
- 7.50safe
- Accruals / assets
- −19.8%clean
- Piotroski F-Score
- 8/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 6 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 3, 2014
- NT 10-Qmissed a reporting deadline ↗Nov 10, 2005
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Shareholder vote · Other material eventDec 22, 2017
- Regulation FD disclosure · Other material eventNov 27, 2017
- Regulation FD disclosure · Other material eventNov 14, 2017
- Results of operationsNov 8, 2017
- Entered a material agreement · Director / officer change · Other material eventOct 6, 2017
- Results of operationsAug 2, 2017
- Other material eventAug 1, 2017
- Director / officer change · Shareholder voteJun 30, 2017
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFeb 13, 2018
- SC 13G/AOMEGA PROTEIN CORPORATIONFeb 9, 2018
- SC 13G/ASCHEDULE 13G/AFeb 9, 2018
- 15-12BFORM 15-12BJan 2, 2018
- 3PRIMARY DOCUMENTDec 29, 2017
- 3PRIMARY DOCUMENTDec 29, 2017
- S-8 POSFORM S-8 POSDec 22, 2017
- S-8 POSFORM S-8 POSDec 22, 2017
- S-8 POSFORM S-8 POSDec 22, 2017
- 8-KFORM 8-KDec 22, 2017
- 4FORM 4 SUBMISSIONDec 21, 2017
- 4FORM 4 SUBMISSIONDec 21, 2017
- 4FORM 4 SUBMISSIONDec 21, 2017
- 4FORM 4 SUBMISSIONDec 21, 2017
- 4FORM 4 SUBMISSIONDec 21, 2017